PHGE

BiomX Announces $3.0 Million Private Placement

12/29 09:00 am

BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis

07/14 09:00 am

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

05/08 07:00 am

Phage Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight

01/23 02:00 pm

BitMart Research: BMX 2024 Annual Report

12/20 12:00 pm

BiomX Announces a Mandatory Unit Separation

10/15 07:00 am

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

08/16 10:55 am

BiomX Inc. Announces Stockholder Approval for Conversion of - GlobeNewswire

07/10 06:32 am

BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024

05/30 07:00 am

BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

05/21 06:30 am

BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024

05/15 07:00 am

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

04/23 08:00 am

BiomX Announces the Appointment of Susan Blum to its Board of Directors

04/18 08:00 am

Here's Why BiomX (PHGE) Is a Great 'Buy the Bottom' Stock Now

04/05 09:55 am

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

04/04 07:49 am

BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

04/03 06:30 am

BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024

03/27 06:30 am

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing

03/18 06:30 am

Trading Penny Stocks With $1,000, Top Tips

03/07 07:08 am

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing

03/06 08:30 am

BiomX (PHGE) Reports Positive Pulmonary Infection Treatment Data

12/04 06:38 am

Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

11/29 03:02 pm

BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

11/29 07:30 am

BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update

11/14 07:30 am

BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the 37th Annual North American Cystic Fibrosis Conference

10/27 08:00 am

BiomX Announces the Appointment of Edward L. Williams to its Board of Directors

10/18 08:00 am

BiomX Announces Completion of Patient Dosing in Part 2 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

10/04 06:34 am

BiomX Reports Second Quarter 2023 Financial Results and Provides Business Update

08/09 06:30 am

BiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023

08/02 04:30 pm

NYSE American Initiates Delisting Proceedings for BiomX Warrants

06/08 05:00 pm

Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session

06/02 01:00 pm

BiomX to Present Part 1 Data from Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis During Late-Breaking Science Session at the 46th European Cystic Fibrosis Conference (ECFC)

05/31 03:00 am

Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

05/24 12:48 pm

BiomX Reports First Quarter 2023 Financial Results and Provides Business Update

05/15 06:30 am

BiomX Announces the Appointments of Jason M. Marks and Michael E. Dambach to Board of Directors

05/12 08:00 am

BiomX to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 15th, 2023

05/08 06:30 am

BiomX Announces Second Closing of $7.5 Million Private Placement

05/05 06:30 am

Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

04/20 01:33 pm

BiomX Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

03/29 06:30 am

Why UiPath Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

03/16 08:22 am

BiomX Announces $7.5 Million Private Placement

02/22 07:35 am

BiomX Announces Positive Results from Part 1 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

02/22 07:30 am

Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

01/20 08:55 am

Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session

12/23 02:24 pm

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session

12/19 02:38 pm

Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket

12/19 07:13 am

BiomX To Present at H.C. Wainwright 1st Annual Investor Conference on Bacteriophage

11/29 10:10 am

Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session

11/28 02:01 pm

BiomX Reports Third Quarter 2022 Financial Results and Provides Business Update

11/09 07:30 am

Why Is Marker Therapeutics Trading Higher By 119%: Here Are 42 Stocks Moving Premarket

08/05 07:35 am